Trial
NCT06357858
ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Case Comprehensive Cancer Center
Collaborators
—
Condition
Recurrent Squamous Cell Carcinoma of the Head and Neck
Intervention
INQOVI (decitabine and cedazuridine)
Why stopped
Funding unavailable
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-03